Raffles Medical Group (RMG)

Investing ideas

Raffles Medical Group sees normalisation in FY2023

Raffles Medical Group is seeing FY2023 normalising from its Covid-19 boost. The group looks to expand overseas moving forward.

Broker's Calls

Higher patient load amid the holiday season keeps RMG at 'add': CGS-CIMB

The recent spike in Covid-19 cases should boost profits for RMG, CGS-CIMB keeps 'add' and $1.20 TP.
Raffles Medical Group balances patient care, growth and shareholder returns - THE EDGE SINGAPORE

Billion Dollar Club 2023

Raffles Medical Group balances patient care, growth and shareholder returns

RMG’s relentless pursuit of excellence in healthcare has transformed it into a formidable healthcare conglomerate.
Analysts downgrade, trim TP on Raffles Medical after 'margins collapsed' in 3QFY2023 - THE EDGE SINGAPORE

Broker's Calls

Analysts downgrade, trim TP on Raffles Medical after 'margins collapsed' in 3QFY2023

Raffles Medical Group posted profit after tax of $12.4 million for the 3QFY2023 ended Sept 30, 67.4% lower y-o-y.

Results

Raffles Medical Group reports 3QFY2023 profit after tax of $12.4 mil, 67.4% lower y-o-y

9MFY2023 PAT fell by 25.6% y-o-y to $72.8 million.

Broker's Calls

UOB Kay Hian keeps ‘buy’ call on Raffles Medical but with lower TP of $1.47 upon Vietnam entry

The analysts say they see downside risks to their FY2023 to FY2025 revenue and earnings estimates for the group. Here's why.
Frasers Centrepoint Trust appoints Raffles Medical’s CIO to board - THE EDGE SINGAPORE

New appointments

Frasers Centrepoint Trust appoints Raffles Medical’s CIO to board

Darren Tan is said to have over 28 years of experience in financial matters.
×